Epilepsy Trial, Recruiting NCT06545643 Sponsor: Duke University Condition: Epilepsy
Back to Epilepsy

Epilepsy Trial, Recruiting

NCT06545643
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are older than 18 years of age
  • People who have at least 2 seizures per week, as recorded in their medical notes
  • People whose seizure medications are expected to remain unchanged throughout the study period
  • People whose brain wave patterns (specifically, at least 40% of certain signals called spikes and spindles) can be detected by a device called the Dreem headband during a screening night of monitoring

Who may not be able to join:

  • People who have cognitive impairment (difficulties with thinking, memory, or understanding)
  • People who have a psychiatric condition that may affect their sleep
  • People who do not have a bed partner or caregiver available to observe their seizures during the study
  • People whose sleep data recorded by the Dreem headband does not closely match expert-reviewed scoring (below 60% agreement)
  • People who have a breathing disorder during sleep, specifically a condition where breathing is disrupted more than 10 times per hour (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Birgit Frauscher, MD PD, Duke University

Phone: 9196139386

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
1 May 2025
Est. completion
1 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Total sleep time (sleep macrostructure); Spike rates per hour (epilepsy marker); Seizure frequency per night (epilepsy marker)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov